|
Post by peppy on Aug 1, 2018 5:34:41 GMT -5
investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-hold-2018-second-quarter-financial-resultsMannKind Corporation to Hold 2018 Second Quarter Financial Results Conference Call on August 2, 2018 WESTLAKE VILLAGE, Calif., July 27, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will host a conference call to discuss the 2018 second quarter and year-to-date financial results and other corporate developments at 5:00 PM (Eastern Time) on Thursday, August 2, 2018. Presenting from the Company will be its Chief Executive Officer, Michael Castagna, Chief Financial Officer, Steven Binder, Chief Commercial Officer, Patrick McCauley and Chief Medical Officer, David Kendall. To view and listen to the earnings call webcast live via the Internet, visit the Company's website at www.mannkindcorp.com and click on the “Q2 2018 MannKind Earnings Conference Call” link in the Webcasts section of News & Events. To participate in the live call by telephone, please dial (800) 239-9838 toll-free or (323) 794-2551 toll/international and use the conference passcode: 5195402. A telephone replay of the call will be accessible for approximately 14 days following completion of the call by dialing (844) 512-2921 toll-free or (412) 317-6671 toll/international and use the replay passcode: 5195402. A replay will also be available on MannKind's website for 14 days.
|
|
|
Post by peppy on Aug 1, 2018 9:31:31 GMT -5
I have a question. Backing the money MNKD owes Deerfield are the MNKD patents correct? If MNKD pays of Deerfield COULD Mike and the board sell some of the patents?
|
|
|
Post by agedhippie on Aug 1, 2018 10:17:19 GMT -5
I have a question. Backing the money MNKD owes Deerfield are the MNKD patents correct? If MNKD pays of Deerfield COULD Mike and the board sell some of the patents? I am not sure if the assets also secure the milestone payments (I suspect not).
|
|
|
Post by peppy on Aug 2, 2018 8:34:34 GMT -5
it looks like the report will be coming out after the close; it did not come out the morning prior to the open.
|
|
|
Post by mike0475 on Aug 2, 2018 8:46:50 GMT -5
Thought the always released prior to call and market open
Speculation will fly
Wrapping up a deal? Bad news?
Dilution
But it’s not Friday...
|
|
|
Post by goyocafe on Aug 2, 2018 8:49:31 GMT -5
Maybe Tanner got its first order from the ministry of health from the UAE. 🤠
|
|
|
Post by mike0475 on Aug 2, 2018 8:50:07 GMT -5
|
|
|
Post by matt on Aug 2, 2018 8:55:11 GMT -5
I have a question. Backing the money MNKD owes Deerfield are the MNKD patents correct? If MNKD pays of Deerfield COULD Mike and the board sell some of the patents? In theory, yes, but there are many other creditors to consider. When a company is highly solvent with many valuable assets (as evaluated at market price, not book value), then there is sufficient security to protect the various parties to which MNKD owes money. Any excess assets belong to the shareholders and can be sold. However, if the balance sheet is weak then the proceeds of any asset sales would have to be used to pay down creditor obligations. The actual ins and outs of what can and cannot be sold falls under the Uniform Fraudulent Conveyances Act which is an entire legal specialty. Suffice it so say that it is complicated. As I have stated before, I am not sure the patents have much value. A patent has little inherent value but becomes valuable only when it protects a successful product from competitors. If the product is in high demand and can command premium pricing in the market (like iPhones) then the patent is valuable, but if the product is a "me too" offering with poor sales (any generic smart phone) the associated patent is nearly worthless. Given the current state of the company it is hard to argue that the patent portfolio has significant value at present. The patents might have value in the future if sales suddenly start growing, but it is hard to monetize future value without those results. Also keep in mind that patents are a ticking time bomb; the longer the company goes without hypergrowth in sales and profits the less valuable the patents are. Many of the key patents are either expired or have short remaining lives, and few buyers will pay good money for a patent that grants less then five years of market exclusivity. Given the time it takes to bring a new medical product to market, in order to have five years of market exclusivity the patent needs to have something greater than ten years of remaining life when sold.
|
|
|
Post by kbrion77 on Aug 2, 2018 8:55:32 GMT -5
Thought the always released prior to call and market open Speculation will fly Wrapping up a deal? Bad news? Dilution But it’s not Friday... My opinion, it will not be pretty.
|
|
|
Post by peppy on Aug 2, 2018 9:08:17 GMT -5
Thought the always released prior to call and market open Speculation will fly Wrapping up a deal? Bad news? Dilution But it’s not Friday... My opinion, it will not be pretty. when mannmade put out an earnings estimate date he came up with @ aug 8. I did as well. aug 2 earnings. I am wondering if they have something to say.
|
|
|
Post by boca1girl on Aug 2, 2018 9:12:24 GMT -5
Thought the always released prior to call and market open Speculation will fly Wrapping up a deal? Bad news? Dilution But it’s not Friday... In the past they announced before the bell and then they had the cc after the bell. But I believe they changed that practice last quarter. I think the earnings release was after the bell last quarter, if I’m not mistaken.
|
|
|
Post by mnkdfann on Aug 2, 2018 9:21:57 GMT -5
when mannmade put out an earnings estimate date he came up with @ aug 8. I did as well. aug 2 earnings. I am wondering if they have something to say. If memory serves, someone over at Seeking Alpha (probably Spencer or matt, but I don't recall for sure) predicted that an earlier earnings date was possible (and has since come to pass) due to the fact that Mannkind changed its accounting method for sales a quarter or two back. The method used now (apparently, IIRC) gives it the ability to predict the numbers it needs for a next quarter's earnings estimate earlier than before.
|
|
|
Post by sportsrancho on Aug 2, 2018 11:14:44 GMT -5
My opinion, it will not be pretty. when mannmade put out an earnings estimate date he came up with @ aug 8. I did as well. aug 2 earnings. I am wondering if they have something to say. Maybe they have somewhere they need to go next week so they moved it up.
|
|
|
Post by brentie on Aug 2, 2018 11:30:56 GMT -5
when mannmade put out an earnings estimate date he came up with @ aug 8. I did as well. aug 2 earnings. I am wondering if they have something to say. If memory serves, someone over at Seeking Alpha (probably Spencer or matt, but I don't recall for sure) predicted that an earlier earnings date was possible (and has since come to pass) due to the fact that Mannkind changed its accounting method for sales a quarter or two back. The method used now (apparently, IIRC) gives it the ability to predict the numbers it needs for a next quarter's earnings estimate earlier than before. It was Spencer. "The first thing that is interesting about this call is the timing. Traditionally, MannKind has its calls about a month and a half after the close of a given quarter. This call is transpiring about a month after the quarter closed. Possible reasons for the earlier-than-expected date are the cause for much discussion. While conspiracy theories are plentiful, the reality could actually be quite simple. With the shift of accounting methods, the company would have a great handle on its revenue story earlier than it would a year ago. MannKind recognizes Afrezza revenue at the time the drug is sold to wholesalers rather than when it is sold to consumers."
|
|
|
Post by straightly on Aug 2, 2018 12:13:44 GMT -5
Thought the always released prior to call and market open Speculation will fly Wrapping up a deal? Bad news? Dilution But it’s not Friday... My opinion, it will not be pretty. Cannot resist when I see the word "speculation", onkly fun left in mnkd town now a days, and even that is getting rare. I actually think it will be pretty pretty IF the meeting was delayed by any event. Reason? Anything bad that can happen, happened.
|
|